$CNO
CNO Financial Group, Inc. Stock $cno

$cno Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000122460819000055 Filed on November 06, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$1.069B	$944.0M	$1.481B
YoY Change	37.37%	-36.27%	37.24%
Cost Of Revenue		$582.8M	$646.9M
YoY Change		-9.91%	1.38%
Gross Profit		$361.2M	$834.3M
YoY Change		-56.71%	89.1%
Gross Profit Margin		38.26%	56.33%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$926.4M	$853.0M	$1.982B
YoY Change	32.08%	-56.97%	116.92%
Operating Profit		$87.90M	$109.0M
YoY Change		-19.36%	-123.06%
Interest Expense	-$35.20M	$37.50M	$38.80M
YoY Change	-11.34%	-3.35%	28.9%
% of Operating Profit		42.66%	35.6%
Other Income/Expense, Net		$1.900M	$0.00
YoY Change
Pretax Income	$107.4M	$53.50M	-$539.8M
YoY Change	189.49%	-109.91%	-515.55%
Income Tax	-$170.6M	$11.50M	-$10.00M
% Of Pretax Income	-158.85%	21.5%
Net Earnings	$278.0M	$42.00M	-$529.8M
YoY Change	882.33%	-107.93%	-625.6%
Net Earnings / Revenue	26.01%	4.45%	-35.77%
Basic Earnings Per Share	$1.85	$0.27	-$3.22
Diluted Earnings Per Share	$1.84	$0.27	-$3.22
COMMON SHARES
Basic Shares Outstanding	151.1M shares	154.3M shares	164.6M shares
Diluted Shares Outstanding		155.3M shares	164.6M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$654.7M	$822.0M	$595.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$25.58B	$25.34B	$23.36B
YoY Change	11.25%	8.48%	-13.68%
Other Assets	$433.0M	$242.0M	$578.0M
YoY Change	-31.27%	-58.13%	1.94%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$33.63B	$33.28B	$31.65B
YoY Change	6.97%	5.16%	-3.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$3.786B	$3.787B	$3.980B
YoY Change	-4.87%	-4.85%	5.85%
Other Long-Term Liabilities	$750.0M	$762.0M	$690.0M
YoY Change	18.67%	10.43%	-12.55%
Total Long-Term Liabilities	$4.536B	$4.549B	$4.670B
YoY Change	-1.65%	-2.59%	2.66%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.536B	$4.549B	$4.670B
Total Liabilities	$28.95B	$28.73B	$28.03B
YoY Change	3.15%	2.49%	0.73%
SHAREHOLDERS EQUITY
Retained Earnings	$535.7M	$274.3M	$184.8M
YoY Change	172.48%	48.43%	-78.31%
Common Stock	$2.769B	$2.836B	$3.032B
YoY Change	-7.6%	-6.45%	-2.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.677B	$4.553B	$3.620B
YoY Change
Total Liabilities & Shareholders Equity	$33.63B	$33.28B	$31.65B
YoY Change	6.97%	5.16%	-3.23%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	$278.0M	$42.00M	-$529.8M
YoY Change	882.33%	-107.93%	-625.6%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$185.8M	$193.2M	-$128.7M
YoY Change	-8.38%	-250.12%	-178.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$354.1M	$8.000M	-$73.70M
YoY Change	67.74%	-110.85%	-175.44%
Cash From Investing Activities	-$354.1M	$8.000M	-$73.70M
YoY Change	67.74%	-110.85%	-175.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.000M	12.90M	52.30M
YoY Change	-98.56%	-75.33%	-115.88%
NET CHANGE
Cash From Operating Activities	185.8M	193.2M	-128.7M
Cash From Investing Activities	-354.1M	8.000M	-73.70M
Cash From Financing Activities	1.000M	12.90M	52.30M
Net Change In Cash	-167.3M	214.1M	-150.1M
YoY Change	-374.26%	-242.64%	120.41%
FREE CASH FLOW
Cash From Operating Activities	$185.8M	$193.2M	-$128.7M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q3	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	-100000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2100000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	-200000	USD
CY2019Q3	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	1500000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	1500000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	162201692	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152183491	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	162201692	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152183491	shares
CY2018Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	319800000	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	39900000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-82300000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-221200000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	93800000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	349100000	USD
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-31792
	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-3108137
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11825 N. Pennsylvania Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmel,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46032
	dei	City Area Code CityAreaCode	(317)
	dei	Local Phone Number LocalPhoneNumber	817-6100
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	151139901	shares
CY2018Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1417200000	USD
CY2019Q3	us-gaap	Notes Payable NotesPayable	988700000	USD
CY2019Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	508900000	USD
CY2018Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	521900000	USD
CY2019Q3	us-gaap	Unearned Premiums UnearnedPremiums	242800000	USD
CY2018Q4	us-gaap	Unearned Premiums UnearnedPremiums	253900000	USD
CY2019Q3	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4200000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21089200000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18447700000	USD
CY2019Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	39300000	USD
CY2018Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	291000000.0	USD
CY2019Q3	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1561700000	USD
CY2018Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1602100000	USD
CY2019Q3	us-gaap	Policy Loans Receivable PolicyLoansReceivable	122800000	USD
CY2018Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	119700000	USD
CY2019Q3	us-gaap	Trading Securities TradingSecurities	247300000	USD
CY2018Q4	us-gaap	Trading Securities TradingSecurities	233100000	USD
CY2019Q3	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1204200000	USD
CY2018Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1468400000	USD
CY2019Q3	us-gaap	Other Investments OtherInvestments	1070900000	USD
CY2018Q4	us-gaap	Other Investments OtherInvestments	833400000	USD
CY2019Q3	us-gaap	Investments Investments	25335400000	USD
CY2018Q4	us-gaap	Investments Investments	22995400000	USD
CY2019Q3	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	760300000	USD
CY2018Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	594200000	USD
CY2019Q3	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	61700000	USD
CY2018Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	62400000	USD
CY2019Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	212700000	USD
CY2018Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	205200000	USD
CY2019Q3	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	284000000.0	USD
CY2018Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	343600000	USD
CY2019Q3	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1138800000	USD
CY2018Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1322500000	USD
CY2019Q3	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4802400000	USD
CY2018Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4925400000	USD
CY2019Q3	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	241500000	USD
CY2018Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	630000000.0	USD
CY2019Q3	us-gaap	Separate Account Assets SeparateAccountAssets	4200000	USD
CY2018Q4	us-gaap	Separate Account Assets SeparateAccountAssets	4400000	USD
CY2019Q3	us-gaap	Other Assets OtherAssets	438800000	USD
CY2018Q4	us-gaap	Other Assets OtherAssets	356700000	USD
CY2019Q3	us-gaap	Assets Assets	33279800000	USD
CY2018Q4	us-gaap	Assets Assets	31439800000	USD
CY2019Q3	us-gaap	Policyholder Funds PolicyholderFunds	11845500000	USD
CY2018Q4	us-gaap	Policyholder Funds PolicyholderFunds	11594100000	USD
CY2019Q3	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11576600000	USD
CY2018Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11082400000	USD
CY2018Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4400000	USD
CY2019Q3	us-gaap	Other Liabilities OtherLiabilities	762000000.0	USD
CY2018Q4	us-gaap	Other Liabilities OtherLiabilities	632400000	USD
CY2019Q3	cno	Investment Borrowings InvestmentBorrowings	1644800000	USD
CY2018Q4	cno	Investment Borrowings InvestmentBorrowings	1645800000	USD
CY2019Q3	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1153000000.0	USD
CY2018Q4	us-gaap	Notes Payable NotesPayable	916800000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	28726500000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	28068900000	USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	1500000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1600000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2834600000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2995000000.0	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1442900000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	177700000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	274300000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	196600000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	4553300000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	3370900000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33279800000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31439800000	USD
CY2019Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	620000000.0	USD
CY2018Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	656900000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1857600000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	1976600000	USD
CY2019Q3	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	275900000	USD
CY2018Q3	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	332000000.0	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	833200000	USD
	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	989300000	USD
CY2019Q3	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	23600000	USD
CY2018Q3	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	85800000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	156600000	USD
	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	134300000	USD
CY2019Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
CY2018Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
CY2019Q3	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	5700000	USD
CY2018Q3	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	33300000	USD
	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	29300000	USD
	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	29100000	USD
CY2019Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	3400000	USD
CY2018Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2100000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	5600000	USD
CY2019Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	2300000	USD
CY2018Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	394600000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	23700000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	390400000	USD
CY2019Q3	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	22200000	USD
CY2018Q3	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	11900000	USD
	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	75700000	USD
	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	44700000	USD
CY2019Q3	us-gaap	Revenues Revenues	944000000.0	USD
CY2018Q3	us-gaap	Revenues Revenues	1481200000	USD
	us-gaap	Revenues Revenues	2946800000	USD
	us-gaap	Revenues Revenues	3535300000	USD
CY2019Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	582800000	USD
CY2018Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	646900000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1816700000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1851700000	USD
CY2019Q3	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	0	USD
CY2018Q3	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	-1067600000	USD
	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	0	USD
	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	-1067600000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	37500000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	38800000	USD
	us-gaap	Interest Expense InterestExpense	117100000	USD
	us-gaap	Interest Expense InterestExpense	110100000	USD
CY2019Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	51600000	USD
CY2018Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	62400000	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	156000000.0	USD
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	195300000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q3	cno	Gain Loss On Extinguishment Of Debt Variable Interest Entities GainLossOnExtinguishmentOfDebtVariableInterestEntities	0	USD
CY2018Q3	cno	Gain Loss On Extinguishment Of Debt Variable Interest Entities GainLossOnExtinguishmentOfDebtVariableInterestEntities	0	USD
	cno	Gain Loss On Extinguishment Of Debt Variable Interest Entities GainLossOnExtinguishmentOfDebtVariableInterestEntities	0	USD
	cno	Gain Loss On Extinguishment Of Debt Variable Interest Entities GainLossOnExtinguishmentOfDebtVariableInterestEntities	-3800000	USD
CY2019Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	218600000	USD
CY2018Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	205300000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	682900000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	608700000	USD
CY2019Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	890500000	USD
CY2018Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2021000000.0	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2780000000.0	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3837200000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	53500000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-539800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	166800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-301900000	USD
CY2019Q3	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	11500000	USD
CY2018Q3	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	-114800000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	35400000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	-63400000	USD
CY2019Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	0	USD
CY2018Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	0	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	42000000.0	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-529800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-343300000	USD
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154257000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	164551000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158007000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165903000	shares
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.07
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	155260000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164551000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159061000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165903000	shares
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	42000000.0	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-529800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-343300000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	619500000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-149100000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1991000000.0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1264100000	USD
CY2019Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	58300000	USD
CY2018Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-18700000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	175000000.0	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-107400000	USD
CY2019Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-124000000.0	USD
CY2018Q3	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	106500000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-200500000	USD
	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	509500000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-2600000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	354700000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	300000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	366400000	USD
CY2019Q3	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	200000	USD
CY2018Q3	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-500000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	600000	USD
	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-100000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	440000000.0	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-379100000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	1615800000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-1013700000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	95300000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-82400000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	350600000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-221400000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	344700000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-296700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1265200000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-792300000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	386700000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-826500000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1396600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1135600000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	4454900000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-529800000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-296100000	USD
CY2018Q3	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	-600000	USD
CY2018Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16600000	USD
CY2018Q3	cno	Stock Based Compensation StockBasedCompensation	8100000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	3619900000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	42000000.0	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	4252200000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	339200000	USD
CY2019Q3	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	5500000	USD
CY2019Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	75300000	USD
CY2019Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16900000	USD
CY2019Q3	cno	Stock Based Compensation StockBasedCompensation	6600000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	4553300000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	4847500000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	4847500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-343300000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-791500000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	-800000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	60500000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	48600000	USD
	cno	Stock Based Compensation StockBasedCompensation	17100000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	3619900000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	3370900000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-3100000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	3367800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131400000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1259600000	USD
	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	5600000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	177300000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	50600000	USD
	cno	Stock Based Compensation StockBasedCompensation	16800000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	4553300000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1726200000	USD
	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	1848100000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	839700000	USD
	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	1005700000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	75700000	USD
	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	44700000	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1224000000.0	USD
	cno	Insurance Policy Benefits InsurancePolicyBenefits	1515600000	USD
	cno	Payment To Reinsurer Pursuant To Long Term Care Business Reinsured PaymentToReinsurerPursuantToLongTermCareBusinessReinsured	0	USD
	cno	Payment To Reinsurer Pursuant To Long Term Care Business Reinsured PaymentToReinsurerPursuantToLongTermCareBusinessReinsured	365000000.0	USD
	us-gaap	Interest Paid Net InterestPaidNet	103900000	USD
	us-gaap	Interest Paid Net InterestPaidNet	92800000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	217500000	USD
	cno	Policy Acquisition Costs PolicyAcquisitionCosts	187200000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	588700000	USD
	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	591900000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3400000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	31000000.0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	510900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115000000.0	USD
	cno	Sales Of Investments SalesOfInvestments	2659300000	USD
	cno	Sales Of Investments SalesOfInvestments	2747200000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1625600000	USD
	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	1966700000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	4387700000	USD
	cno	Purchases Of Investments PurchasesOfInvestments	5037600000	USD
	cno	Net Sales Of Trading Securities NetSalesOfTradingSecurities	6600000	USD
	cno	Net Sales Of Trading Securities NetSalesOfTradingSecurities	-25400000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	92100000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	16300000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-201500000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-314600000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	494200000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	425000000.0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	cno	Expenses Related To Debt Modification And Extinguishment Of Debt ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt	6100000	USD
	cno	Expenses Related To Debt Modification And Extinguishment Of Debt ExpensesRelatedToDebtModificationAndExtinguishmentOfDebt	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000000.0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3500000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	181200000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	67500000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	50600000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	48400000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1307400000	USD
	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1129700000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1017200000	USD
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	980500000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	536800000	USD
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	150000000.0	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	0	USD
	cno	Proceeds From Investment Borrowings Related To Variable Interest Entities ProceedsFromInvestmentBorrowingsRelatedToVariableInterestEntities	277600000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	537700000	USD
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	150600000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	270600000	USD
	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	275900000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-144000000.0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37900000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	165400000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-161700000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	656600000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	757300000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	822000000.0	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	595600000	USD
	cno	Number Of Product Distribution Channels NumberOfProductDistributionChannels	3	distribution_channel
CY2019Q3	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	9200000	USD
CY2018Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	1200000	USD
CY2019Q3	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	2254000000.0	USD
CY2018Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	271300000	USD
CY2019Q3	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-22200000	USD
CY2018Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-4500000	USD
CY2019Q3	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-299100000	USD
CY2018Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-38300000	USD
CY2019Q3	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-98900000	USD
CY2018Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-2500000	USD
CY2019Q3	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-400100000	USD
CY2018Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-49500000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1442900000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	177700000	USD
CY2019Q3	cno	Reduction To Present Value Of Future Profits Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToPresentValueOfFutureProfitsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	12700000	USD
CY2019Q3	cno	Reduction To Deferred Acquisition Costs Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized ReductionToDeferredAcquisitionCostsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	91400000	USD
CY2019Q3	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-98900000	USD
CY2019Q3	cno	Increase To Deferred Tax Assets Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized IncreaseToDeferredTaxAssetsDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	44100000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	376700000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	381200000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1079100000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1127000000.0	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1432300000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1535100000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10648900000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12451200000	USD
CY2019Q3	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	13537000000.0	USD
CY2019Q3	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	15494500000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5264600000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5594700000	USD
CY2019Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	18801600000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21089200000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	405600000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	409800000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1346800000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1377100000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1648200000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1625700000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	9706900000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	9892500000	USD
CY2018Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	13107500000	USD
CY2018Q4	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	13305100000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5000300000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5142600000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	18107800000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18447700000	USD
CY2019Q3	cno	Gain Loss On Investments Before Net Realized Gain Loss On The Transfer Of Assets Related To Reinsurance Transaction GainLossOnInvestmentsBeforeNetRealizedGainLossOnTheTransferOfAssetsRelatedToReinsuranceTransaction	2300000	USD
CY2018Q3	cno	Gain Loss On Investments Before Net Realized Gain Loss On The Transfer Of Assets Related To Reinsurance Transaction GainLossOnInvestmentsBeforeNetRealizedGainLossOnTheTransferOfAssetsRelatedToReinsuranceTransaction	31200000	USD
	cno	Gain Loss On Investments Before Net Realized Gain Loss On The Transfer Of Assets Related To Reinsurance Transaction GainLossOnInvestmentsBeforeNetRealizedGainLossOnTheTransferOfAssetsRelatedToReinsuranceTransaction	23700000	USD
	cno	Gain Loss On Investments Before Net Realized Gain Loss On The Transfer Of Assets Related To Reinsurance Transaction GainLossOnInvestmentsBeforeNetRealizedGainLossOnTheTransferOfAssetsRelatedToReinsuranceTransaction	27000000.0	USD
CY2019Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
CY2018Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
CY2019Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	2300000	USD
CY2018Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	394600000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	23700000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	390400000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	23700000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	5600000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	390400000	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2100000	USD
	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	936600000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	5600000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2100000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Other Than Temporary Impairment Not Credit Loss Net Of Tax Availableforsale Debt Securities AccumulatedOtherComprehensiveIncomeLossOtherThanTemporaryImpairmentNotCreditLossNetOfTaxAvailableforsaleDebtSecurities	500000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	674300000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	5700000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	421300000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	16700000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	1095600000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	22400000	USD
CY2018Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	6310700000	USD
CY2018Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	308600000	USD
CY2018Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1465000000.0	USD
CY2018Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	114700000	USD
CY2018Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	7775700000	USD
CY2018Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	423300000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	42000000.0	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-529800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-343300000	USD
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154257000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	164551000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158007000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	165903000	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1003000	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1054000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	155260000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164551000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159061000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165903000	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2146000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2214000	shares
CY2019Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	924000000.0	USD
CY2018Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1069900000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	2862600000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	3095900000	USD
CY2019Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	836100000	USD
CY2018Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	960900000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2594600000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2787900000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	87900000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	109000000.0	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	268000000.0	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	308000000.0	USD
CY2019Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	924000000.0	USD
CY2018Q3	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	1069900000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	2862600000	USD
	cno	Revenues Excluding Realized Gains Losses RevenuesExcludingRealizedGainsLosses	3095900000	USD
CY2019Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2300000	USD
CY2018Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	31200000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	23700000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	27000000.0	USD
CY2019Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
CY2018Q3	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	0	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransaction	363400000	USD
CY2019Q3	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	12700000	USD
CY2018Q3	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	16700000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	45500000	USD
	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	49000000.0	USD
CY2019Q3	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	5000000.0	USD
CY2018Q3	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	0	USD
	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	15000000.0	USD
	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	0	USD
CY2019Q3	us-gaap	Revenues Revenues	944000000.0	USD
CY2018Q3	us-gaap	Revenues Revenues	1481200000	USD
	us-gaap	Revenues Revenues	2946800000	USD
	us-gaap	Revenues Revenues	3535300000	USD
CY2019Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	836100000	USD
CY2018Q3	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	960900000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2594600000	USD
	cno	Benefits Losses And Expenses Excluding Amortization Related To Realized Gains Losses And Fair Value Changes In Embedded Derivative Liabilities Net Of Related Amortization And Income Taxes BenefitsLossesAndExpensesExcludingAmortizationRelatedToRealizedGainsLossesAndFairValueChangesInEmbeddedDerivativeLiabilitiesNetOfRelatedAmortizationAndIncomeTaxes	2787900000	USD
CY2019Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-37200000	USD
CY2018Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	28200000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-120200000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	69500000	USD
CY2019Q3	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-7900000	USD
CY2018Q3	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	5300000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-25400000	USD
	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	13200000	USD
CY2019Q3	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	200000	USD
CY2018Q3	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	-500000	USD
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	600000	USD
	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	-100000	USD
CY2019Q3	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	12400000	USD
CY2018Q3	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	15900000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	43800000	USD
	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	49100000	USD
CY2019Q3	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-6000000.0	USD
CY2018Q3	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	0	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-22900000	USD
	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	11000000.0	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q3	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	0	USD
CY2018Q3	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	-1067600000	USD
	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	0	USD
	cno	Gain Loss Related To Reinsurance Transaction GainLossRelatedToReinsuranceTransaction	-1067600000	USD
CY2019Q3	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	4600000	USD
CY2018Q3	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	0	USD
	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	14100000	USD
	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	0	USD
CY2019Q3	us-gaap	Other Expenses OtherExpenses	1900000	USD
CY2018Q3	us-gaap	Other Expenses OtherExpenses	0	USD
	us-gaap	Other Expenses OtherExpenses	1900000	USD
	us-gaap	Other Expenses OtherExpenses	0	USD
CY2019Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	890500000	USD
CY2018Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2021000000.0	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2780000000.0	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3837200000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	53500000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-539800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	166800000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-301900000	USD
CY2019Q3	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	11500000	USD
CY2018Q3	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	-114800000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	35400000	USD
	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	-63400000	USD
CY2019Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	0	USD
CY2018Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	0	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	42000000.0	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-529800000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-343300000	USD
CY2019Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Net EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet	117000000	USD
CY2019Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-26900000	USD
CY2018Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	92800000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-34400000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	149400000	USD
CY2019Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	64000000.0	USD
CY2018Q3	us-gaap	Ceded Premiums Written CededPremiumsWritten	25400000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	197300000	USD
	us-gaap	Ceded Premiums Written CededPremiumsWritten	76000000.0	USD
CY2019Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	107600000	USD
CY2018Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	19400000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	328600000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	63600000	USD
CY2019Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	6200000	USD
CY2018Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	7000000.0	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	19100000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	21200000	USD
CY2019Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	9500000	USD
CY2018Q3	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	8600000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	27300000	USD
	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	26600000	USD
CY2019Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4000000.0	USD
CY2018Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-16900000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13300000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3800000	USD
CY2019Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7500000	USD
CY2018Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	50000000.0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	22100000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	80700000	USD
CY2019Q3	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	11500000	USD
CY2018Q3	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	33100000	USD
	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	35400000	USD
	cno	Income Tax Expense Benefit Basedon Estimated Annual Effective Tax Rate IncomeTaxExpenseBenefitBasedonEstimatedAnnualEffectiveTaxRate	84500000	USD
CY2019Q3	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	0	USD
CY2018Q3	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	147900000	USD
	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	0	USD
	cno	Tax Benefit On Longterm Care Reinsurance Transaction TaxBenefitOnLongtermCareReinsuranceTransaction	147900000	USD
CY2019Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	0	USD
CY2018Q3	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	0	USD
	cno	Income Tax Expense Benefit Changein Valuation Allowanceon Discrete Items IncomeTaxExpenseBenefitChangeinValuationAllowanceonDiscreteItems	104800000	USD
CY2019Q3	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	11500000	USD
CY2018Q3	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	-10000000.0	USD
	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	35400000	USD
	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	41400000	USD
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.347
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.015
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.017
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.004
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.212
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.137
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	607000000.0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	685100000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12100000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	14500000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	347600000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	283900000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	46700000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	46300000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1013400000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1029800000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	21600000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	10100000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	164600000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	171100000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	400600000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	50200000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	586800000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	231400000	USD
CY2019Q3	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	426600000	USD
CY2018Q4	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	798400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	193700000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	193700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	232900000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	604700000	USD
CY2019Q3	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	8600000	USD
CY2018Q4	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	25300000	USD
CY2019Q3	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	241500000	USD
CY2018Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	630000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	232900000	USD
CY2019Q3	cno	Deferred Tax Assets Before Valuation Allowance DeferredTaxAssetsBeforeValuationAllowance	426600000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	193700000	USD
CY2019Q3	cno	Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis	0.035
	cno	Valuation Allowance Deferred Tax Asset Valuation Model Forecast Periodof Model ValuationAllowanceDeferredTaxAssetValuationModelForecastPeriodofModel	P5Y
	cno	Adjusted Average Taxable Income AdjustedAverageTaxableIncome	465000000	USD
	cno	Adjusted Average Nonlife Taxable Income AdjustedAverageNonlifeTaxableIncome	85000000	USD
	cno	Adjusted Average Life Taxable Income AdjustedAverageLifeTaxableIncome	380000000	USD
CY2019Q3	cno	Loss Limitation Based On Income Of Life Insurance Company LossLimitationBasedOnIncomeOfLifeInsuranceCompany	0.35
CY2019Q3	cno	Loss Limitation Based On Loss Of Non Life Entities LossLimitationBasedOnLossOfNonLifeEntities	0.35
CY2019Q3	cno	Federal Long Term Tax Exempt Rate FederalLongTermTaxExemptRate	0.0189
CY2019Q3	cno	Nonoperating Loss Carryforwards NonoperatingLossCarryforwards	2238000000.0	USD
CY2019Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2890400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12100000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	14500000	USD
CY2019Q3	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	11300000	USD
CY2018Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	8200000	USD
CY2019Q3	us-gaap	Notes Payable NotesPayable	988700000	USD
CY2018Q4	us-gaap	Notes Payable NotesPayable	916800000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
	cno	Payment Of Redemption Premium PaymentOfRedemptionPremium	6100000	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	1200000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1000000000.0	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	1000000000.0	USD
	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	177300000	USD
CY2019Q3	cno	Stock Repurchase Program Remaining Repurchase Authorized Amount StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount	107300000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	50600000	USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.32
CY2019Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	21200000	USD
	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	4800000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	3800000	USD
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	7600000	USD
CY2019Q3	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	60900000	USD
CY2018Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	43500000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18443700000	USD
CY2019Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	630900000	USD
CY2019Q1	us-gaap	Assets Assets	31436700000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	193500000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	3367800000	USD
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts. We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred. The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict. In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies. Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters. The Company reviews these matters on an ongoing basis. When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On September 29, 2016, Washington National and Bankers Conseco Life Insurance Company ("BCLIC") commenced an arbitration proceeding seeking compensatory, consequential and punitive damages against Beechwood Re Ltd. ("BRe") based upon BRe’s incurable material breaches of the long-term care reinsurance agreements, conversion, fraud, and breaches of fiduciary duties and the obligation to deal honestly and in good faith. BRe filed a counterclaim against Washington National and BCLIC in the arbitration alleging damages relating to the reinsurance agreements and their termination. In addition, on September 29, 2016, a complaint was filed by BCLIC and Washington National in the United States District Court for the Southern District of New York, Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Moshe M. Feuer, Scott Taylor and David Levy, alleging, among other claims, fraud/fraudulent concealment, and violation of the Racketeer Influenced and Corrupt Organizations Act. These allegations relate to the long-term care reinsurance agreements between BRe and Washington National and BCLIC, respectively, and emanate from the undisclosed relationships between and among the defendants (who were the principal owners and officers of BRe) and Platinum Partners, LP and its affiliates. On April 27, 2017, an amended complaint was filed adding Beechwood Capital Group, LLC as a defendant. On March 13, 2018, the District Court granted defendants' motion to compel arbitration of Washington National's and BCLIC's claims and the litigation is now stayed pending the outcome of the arbitration. In connection with the action brought by the PPCO Receiver, discussed below, BCLIC and Washington National reached agreements in October 2019 to settle all claims between themselves and the parties to the arbitration and stayed litigation, namely BRe, Feuer, Taylor, Levy and Beechwood Capital Group, LLC. These settlements involve BCLIC’s and Washington National’s receipt of financial consideration and have been approved by the Grand Court of the Cayman Islands that is presiding over BRe’s winding up proceedings.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By public notice dated July 26, 2017, the Cayman Islands Monetary Authority advised that, effective July 25, 2017, </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> individuals (the "Controllers") had been appointed pursuant to Section 24(2)(h) of the Cayman Islands Insurance Law to assume control of the affairs of BRe. According to the public notice, effective with their appointment, the Controllers assumed immediate control of the affairs of BRe and have all the powers necessary to administer the affairs of BRe including power to terminate its insurance business. The Controllers are responsible for assessing the financial position of BRe and submitting a report to the Cayman Islands Monetary Authority. On August 10, 2018, the Cayman Islands Monetary Authority filed a public petition in the Grand Court of the Cayman Islands to officially wind up BRe, concluding that BRe was now of doubtful solvency. On November 27, 2018, the Grand Court of the Cayman Islands granted the petition to officially wind up BRe and appointed the current Controllers of BRe to be its Joint Official Liquidators. As noted in the previous paragraph, the Grand Court of the Cayman Islands has approved BRe’s settlements with BCLIC and Washington National.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 19, 2018, Melanie Cyganowski, as Equity Receiver for Platinum Partners Credit Opportunities Master Fund, LP and other Platinum entities (the "PPCO Receiver") brought an action in the United States District Court for the Southern District of New York, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski v. Beechwood Re Ltd, et al.</span><span style="font-family:inherit;font-size:10pt;">, alleging, among other claims, fraud, aiding and abetting fraud, fraudulent transfer and violation of the Racketeer Influenced and Corrupt Organizations Act against numerous defendants, including BRe and many of its affiliates, CNO Financial Group, Inc., BCLIC, Washington National and 40\|86 Advisors, Inc. The PPCO Receiver alleges that Platinum insiders conspired with BRe and its principals and affiliates in a massive fraudulent scheme to enrich the Platinum and BRe insiders to the detriment of Platinum investors and creditors. The PPCO Receiver alleges that CNO Financial Group, Inc., BCLIC, Washington National and 40\|86 Advisors, Inc. have liability for the fraudulent scheme of the Platinum and BRe insiders under a theory that they turned a blind eye to the fraudulent scheme due to their desire to transfer unprofitable legacy portfolios of long-term care insurance via the reinsurance transactions with BRe. On January 24, 2019, the court consolidated the PPCO Receiver action with </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> other cases (to which the CNO companies are not parties) before it for at least discovery purposes. On August 19, 2019, the court granted in their entirety CNO Financial Group, Inc.’s and 40\|86 Advisors, Inc.’s motions to dismiss the PPCO Receiver’s claims against them. The court granted in part and denied in part the motions to dismiss of BCLIC and Washington National, dismissing the PPCO Receiver’s claims for, among other things, fraud, aiding and abetting fraud, securities fraud and violation of the Racketeer Influenced and Corrupt Organizations Act, while denying BCLIC’s and Washington National’s motions to dismiss the PPCO </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Receiver’s fraudulent transfer and unjust enrichment claims. Discovery on those remaining claims is now ongoing. BCLIC and Washington National are vigorously contesting the PPCO Receiver’s remaining claims against them.</span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On March 27, 2019, BCLIC and Washington National brought cross-claims and third-party claims in the PPCO Receiver Action against BRe and a number of its affiliates, as well as many Platinum and BRe insiders, alleging that they secretly funded, controlled and operated the BRe enterprise for the benefit of Platinum. BCLIC and Washington National have also brought third-party claims against Lincoln International LLC, which provided valuation services to the BRe enterprise. In October 2019, in exchange for their receiving financial consideration, BCLIC and Washington National have now agreed to settle many of their cross-claims and third-party claims against BRe and a number of its affiliates, as well as many Platinum and BRe insiders. BCLIC and Washington National continue in this litigation to vigorously pursue the remaining cross-claims and third-party claims, including against Lincoln International LLC.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On April 9, 2019, BCLIC and Washington National commenced an action entitled</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Wilmington Trust, National Association</span><span style="font-family:inherit;font-size:10pt;">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "Wilmington Action"). In the Wilmington Action, BCLIC and Washington National assert claims against Wilmington Trust, National Association ("Wilmington") for breaching its express contractual obligations under four trust agreements pursuant to which Wilmington was the trustee in regard to trust assets ceded as part of reinsurance agreements with BRe, as well as for breaching its fiduciary duties to BCLIC and Washington National.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 7, 2019, the Joint Official Liquidators of Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) and Principal Growth Strategies, LLC, commenced suit against, among others, BCLIC, Washington National, 40\|86 Advisors, Inc. and CNO Financial Group, Inc. (collectively, the "CNO Parties") in Delaware Chancery Court. Plaintiffs allege that the CNO Parties were unjustly enriched when they terminated BCLIC and Washington National's reinsurance agreements with BRe and recaptured assets from reinsurance trusts, in particular, Agera securities. Plaintiffs contend that the Agera securities were fraudulently transferred to the Reinsurance Trusts by other Platinum-related entities and they are seeking to claw back those Agera securities, or the value of those assets, from the CNO Parties. The CNO Parties have removed the case to the United States District Court for the District of Delaware and are vigorously contesting the plaintiff's claims.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 28, 2019, BCLIC and Washington National commenced an action entitled </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Bankers Conseco Life Insurance Company and Washington National Insurance Company v. KPMG LLP</span><span style="font-family:inherit;font-size:10pt;">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "KPMG Action"). In the KPMG Action, BCLIC and Washington National assert claims against KPMG LLP ("KPMG") for aiding and abetting fraud, constructive fraud and negligent misrepresentation arising from KPMG's alleged role in the Platinum Partners' scheme to defraud BCLIC and Washington National into reinsuring its long-term care business with BRe.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions. Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers. We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities. The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty. In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries. Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File ("SSADMF") to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>41</span></span><span style="font-family:inherit;font-size:10pt;"> states and the District of </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Columbia participated in this examination. In November 2018, we entered into a Global Resolution Agreement for compliance with laws and regulations concerning the identification, reporting and escheatment of unclaimed contract benefits or abandoned funds. Under the terms of the Global Resolution Agreement, a third-party auditor acting on behalf of the signatory jurisdictions will compare expanded matching criteria to the SSADMF to identify deceased insureds and contract holders where a valid claim has not been made.</span></div>
CY2017Q3	cno	Numberof Individuals Appointedto Assume Immediate Controland Power Over Affairs NumberofIndividualsAppointedtoAssumeImmediateControlandPowerOverAffairs	2	individual
	cno	Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws	41	state
	us-gaap	Net Income Loss NetIncomeLoss	131400000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-343300000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	183700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	216100000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	38800000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10500000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	462500000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	209100000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-150100000	USD
	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-117900000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	217500000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	187200000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	23700000	USD
	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	27000000.0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7300000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction Excluding Cash Expenses NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransactionExcludingCashExpenses	0	USD
	cno	Net Realized Gains On The Transfer Of Assets Related To Reinsurance Transaction Excluding Cash Expenses NetRealizedGainsOnTheTransferOfAssetsRelatedToReinsuranceTransactionExcludingCashExpenses	363400000	USD
	cno	Gain Losson Reinsurance Transaction GainLossonReinsuranceTransaction	0	USD
	cno	Gain Losson Reinsurance Transaction GainLossonReinsuranceTransaction	-1067600000	USD
	cno	Payment To Reinsurer Pursuant To Long Term Care Business Reinsured PaymentToReinsurerPursuantToLongTermCareBusinessReinsured	0	USD
	cno	Payment To Reinsurer Pursuant To Long Term Care Business Reinsured PaymentToReinsurerPursuantToLongTermCareBusinessReinsured	365000000.0	USD
	cno	Gain Loss On Extinguishment Of Debt Variable Interest Entities GainLossOnExtinguishmentOfDebtVariableInterestEntities	0	USD
	cno	Gain Loss On Extinguishment Of Debt Variable Interest Entities GainLossOnExtinguishmentOfDebtVariableInterestEntities	-3800000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	78500000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	11700000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	510900000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115000000.0	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	14700000	USD
	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	19600000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	6300000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	18700000	USD
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	6000000.0	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	18100000	USD
CY2019Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3800000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	18500000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6100000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	23200000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	18300000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	14700000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	10800000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4900000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	78000000.0	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000000.0	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	74000000.0	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0277
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	22200000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	18700000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	14300000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	11000000.0	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8700000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1400000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	76300000	USD
CY2019Q3	cno	Variable Interest Entity Amortized Cost Securities Held VariableInterestEntityAmortizedCostSecuritiesHeld	1227000000.0	USD
CY2019Q3	cno	Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities	2400000	USD
CY2019Q3	cno	Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities	25200000	USD
CY2019Q3	cno	Variable Interest Entity Fixed Maturity Securities Fair Value VariableInterestEntityFixedMaturitySecuritiesFairValue	1204200000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-15800000	USD
	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	-10700000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	10900000	USD
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	276800000	USD
	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	-3200000	USD
	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	3400000	USD
	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	41900000	USD
CY2019Q3	cno	Number Of Investments Held By Variable Interest Entities In Default NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault	0	investment
CY2019Q3	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	590100000	USD
CY2019Q3	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	113300000	USD
	cno	Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage	0.41
CY2019Q3	cno	Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent	0.72
CY2019Q3	cno	Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent	0.93

Files In Submission

Name	View Source	Status
0001224608-19-000055-index-headers.html	Edgar Link	pending
0001224608-19-000055-index.html	Edgar Link	pending
0001224608-19-000055.txt	Edgar Link	pending
0001224608-19-000055-xbrl.zip	Edgar Link	pending
cno-20190930.xsd	Edgar Link	pending
cno-20190930_cal.xml	Edgar Link	unprocessable
cno-20190930_def.xml	Edgar Link	unprocessable
cno-20190930_lab.xml	Edgar Link	unprocessable
cno-20190930_pre.xml	Edgar Link	unprocessable
cno0930201910-q.htm	Edgar Link	pending
cno0930201910-q_htm.xml	Edgar Link	completed
cno09302019ex311.htm	Edgar Link	pending
cno09302019ex312.htm	Edgar Link	pending
cno09302019ex321.htm	Edgar Link	pending
cno09302019ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgchart2019.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2019 Q4 Form 10-Q Financial Statement

#000122460819000055 Filed on November 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2019 Q4 Form 10-Q Financial Statement

#000122460819000055 Filed on November 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno